BioSpace News Archive

Biorelate, the AI company curating biomedical knowledge, today announces the launch of its proprietary tool for accelerated research intelligence, Galactic, at BioData World West 2019.

First and only Adenosine A2A receptor antagonist for use in Parkinson’s disease in the U.S.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, today announced the appointment of Amy C. Peterson, M.D., as executive vice president and chief development officer

cbdMD, Inc. (NYSE American: YCBD), a nationally recognized consumer cannabidiol (CBD) brand, will be auctioning off Team cbdMD Athlete and Americas Rallycross (ARX) driver Steve Arpin’s pink fire suit, with 100 percent of the proceeds going toward supporting those affected by breast cancer.

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has again partnered with iHeartMedia, the number one audio company in the United States, to present the iHeartCountry One Night For Our Military concert on Thursday, November 7,1 at the Country Music Hall of Fame in Nashville

Lipocine Inc. (NASDAQ: LPCN), clinical-stage biopharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will participate in a panel presentation at the B. Riley “NASH-ing in, Let’s All Dig in on What’s to Come at AASLD'19 and EASL'20" NASH symposium being held October 24, 2019 at the Hotel Zelos in San Francisco, CA.

Hoth Therapeutics, Inc. (Nasdaq: HOTH) today announced that the company has made a donation to the National Eczema Association in order to bring continued awareness to National Eczema Awareness Month this Octobe

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced findings from an open-label, single-arm pilot study, which examined the impact of SkinTE™, a novel human cellular and tissue-based product derived from a patient’s own skin, in closing venous stasis leg ulcers (VLUs) following failure of conventional treatments.

Bongo® Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries.

Dr. Wise noted that there are a few implicit issues surrounding the use of AB, “First, there has been some controversy over the cardiovascular safety of aclidinium, which this study shows not to be a problem.